Paydirt
MBX
Ticker

MBX Biosciences, Inc.

MBX

MBX has 5 disclosed filings on Paydirt over the trailing twelve months from 4 corporate insiders: 4 purchases and 1 sale. Filers took a median of 3 days from execution to disclosure, and the most recent trade was executed May 8 and filed May 11. The most active filer was P. Kent Hawryluk with 3 filings.

Add to watchlist
Filings, ttm
5
4 buys · 1 sell
Traders, ttm
4
4 insiders
Volume, ttmiDollar value disclosed in the window
$3.7M
estimated for Congress, as filed for insiders
Median delay
3d
execution to disclosure
Last traded
May 8
Filed May 11
ADViAverage daily dollar volume
–
not on file
Share price · 12M
$66.39 (+231.9%)
$70.70$41.96$13.22Sep 22 2025Mar 10Aug 24

Adjusted for splits and dividends.

Volume by month
$12.0M$6.0M$0Oct 2024Apr 2025Oct 2025Apr 2026Feb 2025 · buys $4.6MSep 2025 · buys $12.0MOct 2025 · buys $538KMar 2026 · buys $526KMay 2026 · sells $2.7M
Buys $17.6M Sells $2.7M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed
PH P. Kent Hawryluk President & CEO 3 filings SA Salomon Azoulay Chief Medical Officer 1 filing CG Carl L Gordon Director 1 filing PH Patrick J Heron Director 1 filing SH Steven L. Hoerter Director 1 filing OL OrbiMed Genesis GP LLC Director 1 filing
Recent filings
Salomon AzoulaySALE Chief Medical Officer $2.7M
70,003 sh across 2 lots
Exec May 8
Filed May 11 · 5:30 PM ET P. Kent HawrylukPURCHASE President & CEO $526K
18,500 sh × $28.41
Exec Mar 13
Filed Mar 16 · 8:02 AM ET P. Kent HawrylukPURCHASE President & CEO $273K
20,000 sh × $13.64
Exec Oct 20 2025
Filed Oct 21 2025 · 5:43 PM ET Steven L. HoerterPURCHASE Director $265K
20,000 sh × $13.25
Exec Oct 17 2025
Filed Oct 20 2025 · 4:44 PM ET Patrick J HeronPURCHASE Director $12.0M
666,666 sh × $18.00
Exec Sep 26 2025
Filed Sep 30 2025 · 4:59 PM ET OrbiMed Genesis GP LLCPURCHASE Director $2.0M
190,672 sh across 4 lots
Exec Feb 14 2025
Filed Feb 19 2025 · 5:30 PM ET Carl L GordonPURCHASE Director $2.0M
190,672 sh across 4 lots
Exec Feb 14 2025
Filed Feb 19 2025 · 5:30 PM ET P. Kent HawrylukPURCHASE President & CEO $534K
50,000 sh × $10.69
Exec Feb 4 2025
Filed Feb 5 2025 · 5:30 PM ET Carl L GordonPURCHASE Director $12.0M
750,000 sh across 2 lots
Exec Sep 16 2024
Filed Sep 17 2024 · 5:30 PM ET Tiba AynechiPURCHASE Director $12.0M
750,000 sh × $16.00
Exec Sep 16 2024
Filed Sep 17 2024 · 5:30 PM ET Patrick J HeronPURCHASE Director $10.0M
625,000 sh × $16.00
Exec Sep 16 2024
Filed Sep 17 2024 · 5:30 PM ET Fhmls X, L.P.PURCHASE 10% owner $10.0M
625,000 sh × $16.00
Exec Sep 16 2024
Filed Sep 17 2024 · 5:30 PM ET NEA Partners 17, L.P.PURCHASE 10% owner $8.0M
500,000 sh × $16.00
Exec Sep 16 2024
Filed Sep 17 2024 · 5:30 PM ET Orbimed Advisors LlcPURCHASE Director $12.0M
750,000 sh across 2 lots
Exec Sep 16 2024
Filed Sep 17 2024 · 5:30 PM ET Scott D SandellPURCHASE 10% owner $8.0M
500,000 sh × $16.00
Exec Sep 16 2024
Filed Sep 17 2024 · 5:30 PM ET Rick YangPURCHASE 10% owner $8.0M
500,000 sh × $16.00
Exec Sep 16 2024
Filed Sep 17 2024 · 5:30 PM ET Paul Edward WalkerPURCHASE 10% owner $8.0M
500,000 sh × $16.00
Exec Sep 16 2024
Filed Sep 17 2024 · 5:30 PM ET Mohamad MakhzoumiPURCHASE 10% owner $8.0M
500,000 sh × $16.00
Exec Sep 16 2024
Filed Sep 17 2024 · 5:30 PM ET Anthony A. Florence Jr.PURCHASE 10% owner $8.0M
500,000 sh × $16.00
Exec Sep 16 2024
Filed Sep 17 2024 · 5:30 PM ET Carmen ChangPURCHASE 10% owner $8.0M
500,000 sh × $16.00
Exec Sep 16 2024
Filed Sep 17 2024 · 5:30 PM ET Ali BehbahaniPURCHASE 10% owner $8.0M
500,000 sh × $16.00
Exec Sep 16 2024
Filed Sep 17 2024 · 5:30 PM ET Forest BaskettPURCHASE 10% owner $8.0M
500,000 sh × $16.00
Exec Sep 16 2024
Filed Sep 17 2024 · 5:30 PM ET Edward T MathersPURCHASE Director $8.0M
500,000 sh × $16.00
Exec Sep 16 2024
Filed Sep 17 2024 · 5:30 PM ET